Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion type Assertion NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_head.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion description "[The expanded fold values of CD45(+) white blood cells and CD34(+), CD133(+), CD34(+)CD38(-), CD133(+)CD38(-), CD34(+)CD133(+), colony-forming and long-term culture-initiating cells at the end of 7-day culture from CD133(+) MPB of hematologic malignancies were 9.4-fold, 5.9-fold, 4.0-fold, 35.8-fold, 21.9-fold, 3.8-fold, 11.8-fold and 6.7-fold, and values from healthy donor CD133(+) MPB were 20.7-fold, 14.5-fold, 8.5-fold, 83.8-fold, 37.3-fold, 6.2-fold, 19.1-fold and 14.6-fold.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_provenance.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion evidence source_evidence_literature NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_provenance.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion SIO_000772 23768928 NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_provenance.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion wasDerivedFrom befree-2016 NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_provenance.
- NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_assertion wasGeneratedBy ECO_0000203 NP1086089.RAQFpD54IbPVi9xGUgGBeTu0Ft8CCb6h2YB1gcYU9H2ko130_provenance.